New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aeterna Zentaris Inc.
AEZS.TO
Shape
US Flag

TSX

Unprofitable

Unprofitable

25M

Biotechnology

Next Earning date - 06 Nov 2024

25M

Biotechnology

Next Earning date - 06 Nov 2024

8.29CAD
Shape0.62 ( 8.08%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-31%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated October 24, 2024
1W % 1M % 3M -30.13 % 1Y -35.95 %

Key Metrics

Shape
  • Market Cap

    25.38M


  • Shares Outstanding

    3.06M


  • Share in Float

    1.20M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    8.29


  • Average Volume

    1788


  • Beta

    2.257


  • Range

    0.19-12.5


  • Industry

    Biotechnology


  • Website

    https://www.zentaris.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.73x

P/S Ratio

0.14x

P/B Ratio

0.0

Debt/Equity

-760.3%

Net Margin

$-3.2

EPS

How AEZS.TO compares to sector?

P/E Ratio

Relative Strength

Shape

AEZS.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape110716%

2024-Revenue

$13.90

Shape27%

2024-EPS

$4M

Shape28%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.87
vs -0.52

Q3.22

arrow
arrow

N/A

-0.70
vs -0.25

Q4.22

arrow
arrow

N/A

-0.87
vs -0.50

Q1.23

arrow
arrow

N/A

-0.88
vs -0.50

Q2.23

arrow
arrow

N/A

-0.52
vs -0.87

Q3.23

arrow
arrow

N/A

-0.85
vs -0.70

Q4.23

arrow
arrow

N/A

-1.16
vs -0.87

Q1.24

arrow
arrow

N/A

-25.72
vs -0.88

Q2.24

arrow
arrow

N/A

-3.28
vs -0.52

Q3.24

arrow
arrow

N/A

-3.53
vs -0.85

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-137%

-222000.00  vs 599K

Q3.22

arrow
arrow

+209%

1.9M  vs 602K

Q4.22

arrow
arrow

+160%

2.5M  vs 956K

Q1.23

arrow
arrow

+40%

2.1M  vs 1.5M

Q2.23

arrow
arrow

+1112%

2.2M  vs -222000

Q3.23

arrow
arrow

-100%

3K  vs 1.9M

Q4.23

arrow
arrow

-95%

121K  vs 2.5M

Q1.24

arrow
arrow

-100%

4K  vs 2.1M

Q2.24

arrow
arrow

-51%

1.1M  vs 2.2M

Q3.24

arrow
arrow

+37086%

1.1M  vs 3K

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-7%

-0.07
vs -0.05

Q3.22

arrow
arrow

-6%

-0.06
vs -0.07

Q4.22

arrow
arrow

-58%

-0.58
vs -0.06

Q1.23

arrow
arrow

-14%

-0.14
vs -0.58

Q2.23

arrow
arrow

-9%

-0.09
vs -0.14

Q3.23

arrow
arrow

-16%

-0.16
vs -0.09

Q4.23

arrow
arrow

-31%

-0.31
vs -0.16

Q1.24

arrow
arrow

-44%

-0.44
vs -0.31

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News